These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 1680449

  • 21. Importance of iron saturation for erythropoietin responsiveness in chronic peritoneal dialysis.
    Jonnalagadda V, Bloom EJ, Raja RM.
    Adv Perit Dial; 1997; 13():113-5. PubMed ID: 9360662
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Effect of recombinant human erythropoietin (rHu-EPO) on anemia and selected biochemical parameters in patients in the pre-dialysis period].
    Sułowicz W, Drozdz M, Hanicki Z, Kraśniak A, Kuźniewski M.
    Przegl Lek; 1992; 49(1-2):50-3. PubMed ID: 1455007
    [Abstract] [Full Text] [Related]

  • 24. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
    Jalil R, Vaccarezza A, Jara A, Lira P, Vial S, Serrano V.
    Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783
    [Abstract] [Full Text] [Related]

  • 25. The efficiency of fractionated parenteral iron treatment in CAPD patients.
    Akcicek F, Ozkahya M, Cirit M, Ok E, Unsal A, Toz H, Celik A, Atabay G, Basci A.
    Adv Perit Dial; 1997 Jun; 13():109-12. PubMed ID: 9360661
    [Abstract] [Full Text] [Related]

  • 26. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N, Osman-Malik Y, Frinak S, Besarab A.
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The effect of subcutaneous recombinant human erythropoietin (r-Hu EPO) in CAPD patients with renal anaemia.
    Janicka L, Ksiazek A, Baranowicz I, Mierzicki P.
    Ann Univ Mariae Curie Sklodowska Med; 1994 Apr; 48 Suppl 3():67-77. PubMed ID: 8192534
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC).
    Pizzarelli F, David S, Sala P, Icardi A, Casani A.
    Am J Kidney Dis; 2006 Jun; 47(6):1027-35. PubMed ID: 16731298
    [Abstract] [Full Text] [Related]

  • 31. [Anemia in patients on continuous ambulatory peritoneal dialysis (CAPD)].
    Tokuda Y, Itou H, Uchida Y, Azuma K, Ohtsuka H, Uomizu K, Yamashita W, Harada R, Nakashima A, Morita T.
    Fukuoka Igaku Zasshi; 1989 Jul; 80(7):379-84. PubMed ID: 2807127
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B, Grujić-Adanja G.
    Srp Arh Celok Lek; 1997 Jul; 125(5-6):163-7. PubMed ID: 9265238
    [Abstract] [Full Text] [Related]

  • 34. Erythropoietin resistance in patients on continuous ambulatory peritoneal dialysis.
    Nakamoto H, Kanno Y, Okada H, Suzuki H.
    Adv Perit Dial; 2004 Jul; 20():111-6. PubMed ID: 15384808
    [Abstract] [Full Text] [Related]

  • 35. Treatment of anaemia in CAPD patients with recombinant human erythropoietin.
    Ramello A, Malcangi U, Bruno M, Perosa P, Reina E, Rizzuto A, Nasini MG, Carozzi S.
    Adv Perit Dial; 1990 Jul; 6():308-11. PubMed ID: 1982834
    [Abstract] [Full Text] [Related]

  • 36. One year experience with subcutaneous human erythropoietin in CAPD: correction of renal anemia and increased ultrafiltration.
    Lubrich-Birkner I, Schollmeyer P, Steinhauer HB.
    Adv Perit Dial; 1990 Jul; 6():302-7. PubMed ID: 1982833
    [Abstract] [Full Text] [Related]

  • 37. Effect of continuous ambulatory peritoneal dialysis on anemia in uremic patients.
    Marcovici O, Boner G, Rosenfeld JB.
    Isr J Med Sci; 1983 Jul; 19(7):604-7. PubMed ID: 6885343
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Clinical efficacy of recombinant human erythropoietin in hemodialysis patients.
    Mohini R.
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):16-21. PubMed ID: 2648516
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.